1846 — EuroEyes International Eye Clinic Share Price
- HK$897.98m
- HK$596.78m
- HK$715.68m
- 93
- 74
- 31
- 77
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.84 | ||
Price to Tang. Book | 1.13 | ||
Price to Free Cashflow | 7.78 | ||
Price to Sales | 1.28 | ||
EV to EBITDA | 2.69 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 8% | ||
Return on Equity | 7.39% | ||
Operating Margin | 16.18% |
Financial Summary
Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 473.82 | 632.93 | 610.29 | 714.29 | 715.68 | 799.15 | n/a | 10.74% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +78.6 | +139.58 | -34.23 | +48.11 | -30.89 | +19.5 | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Euroeyes International Eye Clinic Ltd is a Germany-based company engaged in the optical industry. The Company provides various services for vision correction, such as refractive laser surgery, phakic lens surgery and lens exchange surgery. The Company operates in Germany, Denmark and China.
Directors
- Jorn Jorgensen CHM (65)
- Markus Braun CFO (46)
- Ralf-Christian Lerche SVP (51)
- Lars Boberg-Ans SVP (63)
- Michael Knorz SVP (60)
- Keith McKay SVP (50)
- Jannik Jorgensen VPR (28)
- Junjie Ni VPR (36)
- Kai Weber VPR (46)
- Yan Wang VPR (49)
- Jorg Hassel OTH (58)
- Rosenna Ho SEC
- Marcus Bracklo NED (55)
- Hans Hennig NID (61)
- Philip Wright NID (65)
- Rong Xin NID (57)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 12th, 2018
- Public Since
- October 15th, 2019
- No. of Employees
- 322
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 320,706,000

- Address
- Valentinskamp 90, HAMBURG, 20355
- Web
- https://www.euroeyes.hk/
- Phone
- Auditors
- PricewaterhouseCoopers Hongkong
Upcoming Events for 1846
Dividend For 1846.HK - 0.0297 HKD
Half Year 2025 Euroeyes International Eye Clinic Ltd Earnings Release
Similar to 1846
Adicon Holdings
Stock Exchange of Hong Kong Limited
Aidigong Maternal & Child Health
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 20:30 UTC, shares in EuroEyes International Eye Clinic are trading at HK$2.85. This share price information is delayed by 15 minutes.
Shares in EuroEyes International Eye Clinic last closed at HK$2.85 and the price had moved by -40.63% over the past 365 days. In terms of relative price strength the EuroEyes International Eye Clinic share price has underperformed the FTSE Developed Asia Pacific Index by -39.95% over the past year.
The overall consensus recommendation for EuroEyes International Eye Clinic is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe EuroEyes International Eye Clinic dividend yield is 2.27% based on the trailing twelve month period.
Last year, EuroEyes International Eye Clinic paid a total dividend of HK$0.06, and it currently has a trailing dividend yield of 2.27%.Looking ahead, shares in EuroEyes International Eye Clinic are due to go ex-dividend on 2025-06-10 and the next dividend pay date is 2025-06-27.
EuroEyes International Eye Clinic are due to go ex-dividend on 2025-06-10 and the next dividend pay date is 2025-06-27. The historic dividend yield on EuroEyes International Eye Clinic shares is currently 2.27%.
To buy shares in EuroEyes International Eye Clinic you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$2.85, shares in EuroEyes International Eye Clinic had a market capitalisation of HK$897.98m.
Here are the trading details for EuroEyes International Eye Clinic:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1846
Based on an overall assessment of its quality, value and momentum EuroEyes International Eye Clinic is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in EuroEyes International Eye Clinic is HK$6.29. That is 120.87% above the last closing price of HK$2.85.
Analysts covering EuroEyes International Eye Clinic currently have a consensus Earnings Per Share (EPS) forecast of HK$0.34 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like EuroEyes International Eye Clinic. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -35.19%.
As of the last closing price of HK$2.85, shares in EuroEyes International Eye Clinic were trading -29.91% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The EuroEyes International Eye Clinic PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$2.85.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
EuroEyes International Eye Clinic's management team is headed by:
- Jorn Jorgensen - CHM
- Markus Braun - CFO
- Ralf-Christian Lerche - SVP
- Lars Boberg-Ans - SVP
- Michael Knorz - SVP
- Keith McKay - SVP
- Jannik Jorgensen - VPR
- Junjie Ni - VPR
- Kai Weber - VPR
- Yan Wang - VPR
- Jorg Hassel - OTH
- Rosenna Ho - SEC
- Marcus Bracklo - NED
- Hans Hennig - NID
- Philip Wright - NID
- Rong Xin - NID